The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

EuroIntervention 2018;13:2047-2050 published online September 2017. DOI: 10.4244/EIJ-D-17-00529

1. Boston Scientific Corporation, Marlborough, MA, USA; 2. Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium; 3. University Hospital Leuven, Leuven, Belgium; 4. Ziekenhuis Oost Limburg, Genk, Belgium; 5. Clinique Pasteur, Toulouse, France; 6. Univ

Aims: Long-term data on bioabsorbable polymer-coated everolimus-eluting stents (BP-EES) are limited. The EVOLVE trial compared the safety and efficacy of two dose formulations of the SYNE

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Clinical implications of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention for chronic total occlusion: role of antegrade and retrograde crossing techniques